1. A monthly withdrawal bleed (triggered by several days’ worth of hormone-free pills in each pack) has been shown to help prevent:
2. Guidelines put out by the Society of Obstetricians and Gynaecologists of Canada stipulate that continuous OC pills (without monthly bleeding) should be used only in women suffering from dysmenorrhea.
3. The risk of venous thromboembolism in OCP users, compared to matched controls, is elevated:
4. Evidence suggests that low-estrogen formulations bring lower risk of VTE.
5. Occasionally, the Pill is stopped before surgery due to its procoagulant effects. How long must it be discontinued before these effects wear off?
6. Which of the following, according to WHO guidelines, is NOT an absolute contraindication to OCP use?
We'll send you $100 if we print your diagnostic challenge. Send case description (app. 450 words) with final diagnosis and outcome to: parkex@parkpub.com.